{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:13:08Z","timestamp":1772755988085,"version":"3.50.1"},"reference-count":35,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,8,1]]},"abstract":"<jats:p>OBJECTIVE. Before 1991, Alaska Native children experienced one of the highest rates of invasive Haemophilus influenzae type b disease. H influenzae type b vaccine has led to a near-elimination of invasive H influenzae type b disease in the United States. We describe challenges encountered in controlling H influenzae type b disease in Alaska and update the current status of H influenzae disease and carriage in Alaska as lessons to other populations.<\/jats:p><jats:p>PATIENTS AND METHODS. We reviewed data from statewide H influenzae disease surveillance conducted during 1980\u20132004. Vaccine coverage data were based on audits from tribal facilities and the National Immunization Survey. H influenzae type b colonization data were based on 6 carriage studies.<\/jats:p><jats:p>RESULTS. After universal infant vaccination in 1991, H influenzae type b disease among Alaska Native and non-Native children &amp;lt;5 years of age decreased by 94% and 96%, respectively. After a 1996 change in H influenzae type b vaccine from polyribosylribitol phosphate-outer membrane protein conjugate vaccine to H influenzae type b oligosaccharide-CRM197 vaccine, the incidence of H influenzae type b disease increased in rural Alaska Natives from 19.8 to 91.1 cases per 100000 per year &amp;lt;5 years of age. During 2001\u20132004, with use of polyribosylribitol phosphate-outer membrane protein conjugate vaccine, the rate of H influenzae type b disease in Alaska Native and non-Native children aged &amp;lt;5 years decreased to 5.4 and 0 per 100000 per year, respectively. In postvaccine studies, H influenzae type b carriage has decreased in Alaska Native children &amp;lt;5 years of age.<\/jats:p><jats:p>CONCLUSIONS. H influenzae type b vaccination has resulted in a dramatic decrease in invasive H influenzae type b disease in Alaska; however, despite high rates of H influenzae type b vaccine coverage, H influenzae type b disease rates among rural Alaska Native children &amp;lt;5 years of age remain higher than the rates among non-Native Alaska and other US children. Equity in disease rates may not be achieved in indigenous populations with the current vaccines unless other environmental and household factors contributing to disease transmission are addressed.<\/jats:p>","DOI":"10.1542\/peds.2006-0287","type":"journal-article","created":{"date-parts":[[2006,8,2]],"date-time":"2006-08-02T17:07:56Z","timestamp":1154538476000},"page":"e421-e429","source":"Crossref","is-referenced-by-count":68,"title":["The Alaska<i>Haemophilus influenzae<\/i>Type b Experience: Lessons in Controlling a Vaccine-Preventable Disease"],"prefix":"10.1542","volume":"118","author":[{"given":"Rosalyn","family":"Singleton","sequence":"first","affiliation":[{"name":"Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska"},{"name":"Alaska Native Tribal Health Consortium, Anchorage, Alaska"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Hammitt","sequence":"additional","affiliation":[{"name":"Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska"},{"name":"Alaska Native Tribal Health Consortium, Anchorage, Alaska"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hennessy","sequence":"additional","affiliation":[{"name":"Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Bulkow","sequence":"additional","affiliation":[{"name":"Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolynn","family":"DeByle","sequence":"additional","affiliation":[{"name":"Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Parkinson","sequence":"additional","affiliation":[{"name":"Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tammy E.","family":"Cottle","sequence":"additional","affiliation":[{"name":"Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Peters","sequence":"additional","affiliation":[{"name":"Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay C.","family":"Butler","sequence":"additional","affiliation":[{"name":"Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2006,8,1]]},"reference":[{"key":"2021120822383451000_R1","doi-asserted-by":"crossref","unstructured":"Bisgard KM, Kao A, Leake J, Strebel PM, Perkins BA, Wharton M. Haemophilus influenzae invasive disease in the United States, 1994\u20131995: near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis.\u20081998;4:229\u2013237","DOI":"10.3201\/eid0402.980210"},{"key":"2021120822383451000_R2","doi-asserted-by":"crossref","unstructured":"Broome CV. Epidemiology of Haemophilus influenzae type b infections in the United States. Pediatr Infect Dis J.\u20081987;6:779\u2013782","DOI":"10.1097\/00006454-198708000-00036"},{"key":"2021120822383451000_R3","doi-asserted-by":"crossref","unstructured":"Ward JI, Lum MK, Hall DB, Silimperi DR, Bender TR. Invasive Haemophilus influenzae type b disease in Alaska: background epidemiology for a vaccine efficacy trial. J Infect Dis.\u20081986;153:17\u201326","DOI":"10.1093\/infdis\/153.1.17"},{"key":"2021120822383451000_R4","doi-asserted-by":"crossref","unstructured":"Ward JI, Margolis HS, Lum MK, Fraser DW, Bender TR, Anderson P. Haemophilus influenzae disease in Alaskan Eskimos: characteristics of a population with an unusual incidence of invasive disease. Lancet.\u20081982;1:1281\u20131285","DOI":"10.1016\/S0140-6736(81)92458-2"},{"key":"2021120822383451000_R5","doi-asserted-by":"crossref","unstructured":"Hall DB, Lum MK, Knutson LR, Heyward WL, Ward JI. Pharyngeal carriage and acquisition of anticapsular antibody to Haemophilus influenzae type b in a high-risk population in southwestern Alaska. Am J Epidemiol.\u20081987;126:1190\u20131197","DOI":"10.1093\/oxfordjournals.aje.a114758"},{"key":"2021120822383451000_R6","doi-asserted-by":"crossref","unstructured":"Galil K, Singleton R, Levine OS, et al. Re-emergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. J Infect Dis.\u20081999;179:101\u2013106","DOI":"10.1086\/314569"},{"key":"2021120822383451000_R7","doi-asserted-by":"crossref","unstructured":"Singleton R, Bulkow LR, Levine OS, Butler JC, Hennessy TW, Parkinson A. Experience with the prevention of invasive Haemophilus influenzae type b disease by vaccination in Alaska: The impact of persistent oropharyngeal carriage. J Pediatr.\u20082000;137:313\u2013320","DOI":"10.1067\/mpd.2000.107843"},{"key":"2021120822383451000_R8","doi-asserted-by":"crossref","unstructured":"Falla G, Crook D, Brophy L, Maskell D, Kroll J, Moxon E. PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol.\u20081994;32:2382\u20132386","DOI":"10.1128\/jcm.32.10.2382-2386.1994"},{"key":"2021120822383451000_R9","unstructured":"Hennessy T, Singleton R, Bulkow L, et al. Persistent Haemophilus influenzae type b (Hib) carriage among children and adults in rural Alaska Native villages with high invasive disease rates. In: 39th Annual Meeting of the Infectious Diseases Society of America; October 25, 2001; San Francisco, CA"},{"key":"2021120822383451000_R10","unstructured":"Ward J, Leiberman JM, Cochi SL. Haemophilus influenzae Vaccines. 2nd ed. Philadelphia, PA: WB Saunders Co; 1994"},{"key":"2021120822383451000_R11","doi-asserted-by":"crossref","unstructured":"Ward JI, Brenneman G, Letson GW, Heyward WL, and the Alaska Haemophilus influenzae Vaccine Study group. Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. N Engl J Med.\u20081990;323:1393\u20131401","DOI":"10.1056\/NEJM199011153232006"},{"key":"2021120822383451000_R12","doi-asserted-by":"crossref","unstructured":"Singleton RJ, Davidson NM, DeSmet IJ, et al. Decline of Haemophilus influenzae type b disease in a region of high risk: impact of passive and active immunization. Pediatr Infect Dis J.\u20081994;13:362\u2013367","DOI":"10.1097\/00006454-199405000-00006"},{"key":"2021120822383451000_R13","doi-asserted-by":"crossref","unstructured":"Bulkow LR, Wainwright RB, Letson GW, Chang SJ, Ward JI. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants. Pediatr Infect Dis J.\u20081993;12:484\u2013492","DOI":"10.1097\/00006454-199306000-00006"},{"key":"2021120822383451000_R14","doi-asserted-by":"crossref","unstructured":"Decker MD, Edwards KM, Bradley R, Palmer P. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J Pediatr.\u20081992;120:184\u2013189","DOI":"10.1016\/S0022-3476(05)80424-X"},{"key":"2021120822383451000_R15","doi-asserted-by":"crossref","unstructured":"Granoff DM, Anderson EL, Osterholm MT, et al. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. J Pediatr.\u20081992;121:187\u2013194","DOI":"10.1016\/S0022-3476(05)81186-2"},{"key":"2021120822383451000_R16","unstructured":"Centers for Disease Control and Prevention. Vaccination coverage levels among Alaska Native children aged 19\u201335 months \u2014National Immunization Survey, United States, 2000\u20132001. MMWR Morb Mortal Wkly Rep.\u20082003;52:710\u2013713"},{"key":"2021120822383451000_R17","doi-asserted-by":"crossref","unstructured":"Millar EV, O\u2019Brien KL, Watt JP, et al. Epidemiology of invasive Haemophilus influenzae type a disease among Navajo and White Mountain Apache children, 1988\u20132003. Clin Infect Dis.\u20082005;40:823\u2013830","DOI":"10.1086\/428047"},{"key":"2021120822383451000_R18","unstructured":"Hanna JN. Impact of Haemophilus influenzae type b (Hib) vaccination on Hib meningitis in children in Far North Queensland, 1989 to 2003. Commun Dis Intell.\u20082004;28:255\u2013257"},{"key":"2021120822383451000_R19","doi-asserted-by":"crossref","unstructured":"Scheifele D, Halperin S, Law B, King A. Invasive Haemophilus influenzae type b infections in vaccinated and unvaccinated children in Canada, 2001\u20132003. Can Med Assoc J.\u20082005;172:53\u201356","DOI":"10.1503\/cmaj.1031861"},{"key":"2021120822383451000_R20","doi-asserted-by":"crossref","unstructured":"Holmes SJ, Granoff DM. The biology of Haemophilus influenzae type b vaccination failure. J Infect Dis.\u20081992;165(suppl 1):S121\u2013S128","DOI":"10.1093\/infdis\/165-Supplement_1-S121"},{"key":"2021120822383451000_R21","doi-asserted-by":"crossref","unstructured":"Heath PT, Booy R, Griffiths H, et al. Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin Infect Dis.\u20082000;31:973\u2013980","DOI":"10.1086\/318132"},{"key":"2021120822383451000_R22","doi-asserted-by":"crossref","unstructured":"Holmes SJ, Lucas AH, Osterholm MT, Froeschle JE, Granoff DM, the Collaborative Study Group. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. JAMA.\u20081991;266:1960\u20131965","DOI":"10.1001\/jama.266.14.1960"},{"key":"2021120822383451000_R23","doi-asserted-by":"crossref","unstructured":"Santosham M, Hill J, Wolff M, Reid R, Lukacs L, Ahonkhai V. Safety and immunogenicity of a Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population. Pediatr Infect Dis J.\u20081991;10:113\u2013117","DOI":"10.1097\/00006454-199102000-00007"},{"key":"2021120822383451000_R24","doi-asserted-by":"crossref","unstructured":"Campbell H, Byass P, Ahonkhai VI, Vella PP, Greenwood BM. Serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in very young Gambian infants. Pediatrics.\u20081990;86:102\u2013107","DOI":"10.1542\/peds.86.1.102"},{"key":"2021120822383451000_R25","doi-asserted-by":"crossref","unstructured":"Daum RS, Siber GB, Ballanco GA, Sood SK. Serum anticapsular antibody response in the first week after immunization of adults and infants with the Haemophilus influenzae type b-Neisseria meningitidis outer membrane protein complex conjugate vaccine. J Infect Dis.\u20081991;164:1154\u20131159","DOI":"10.1093\/infdis\/164.6.1154"},{"key":"2021120822383451000_R26","doi-asserted-by":"crossref","unstructured":"Slack MP, Azzopardi HJ, Hargreaves RM, Ramsay ME. Enhanced surveillance of invasive Haemophilus influenzae disease in England, 1990\u20131996: impact of conjugate vaccines. Ped Infect Dis J.\u20081998;17(suppl 9):S204\u2013S207","DOI":"10.1097\/00006454-199809001-00026"},{"key":"2021120822383451000_R27","doi-asserted-by":"crossref","unstructured":"Hammitt LL, Block S, Hennessy T, et al. Outbreak of invasive. Haemophilus influenzae serotype a disease. Pediatr Infect Dis J.\u20082005;24:453\u2013456","DOI":"10.1097\/01.inf.0000160954.90881.29"},{"key":"2021120822383451000_R28","doi-asserted-by":"crossref","unstructured":"Barbour M. Conjugate vaccine and carriage of Haemophilus influenzae type b. Emerg Infect Dis.\u20081996;2:176\u2013182","DOI":"10.3201\/eid0203.960303"},{"key":"2021120822383451000_R29","doi-asserted-by":"crossref","unstructured":"Mohle-Boetani J, Ajello G, Greneman E, et al. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr Infect Dis J.\u20081993;12:589\u2013593","DOI":"10.1097\/00006454-199307000-00009"},{"key":"2021120822383451000_R30","doi-asserted-by":"crossref","unstructured":"Takala A, Santosham M, Almeido-Hill J, et al. Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of. Haemophilus influenzae type b among American Indian children. Ped Infect Dis J.\u20081993;12:593\u2013599","DOI":"10.1097\/00006454-199307000-00010"},{"key":"2021120822383451000_R31","doi-asserted-by":"crossref","unstructured":"Michaels R, Poziviak C, Stonebraker F, Norden C. Factors affecting pharyngeal Haemophilus influenzae type b colonization rates in children. J Clin Microbiol.\u20081976;4:413\u2013417","DOI":"10.1128\/jcm.4.5.413-417.1976"},{"key":"2021120822383451000_R32","doi-asserted-by":"crossref","unstructured":"Millar EV, O\u2019Brien KL, Levine OS, Kvamme S, Reid R, Santosham M. Toward elimination of Haemophilus influenzae type b carriage and disease among high-risk American Indian children. Am J Public Health.\u20082000;2000:1550\u20131552","DOI":"10.2105\/AJPH.90.10.1550"},{"key":"2021120822383451000_R33","doi-asserted-by":"crossref","unstructured":"Fernandez J, Levine O, Sanchez J, et al. Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration. J Infect Dis.\u20082000;182:1553\u20131556","DOI":"10.1086\/315870"},{"key":"2021120822383451000_R34","doi-asserted-by":"crossref","unstructured":"Perdue DG, Bulkow LR, Gellin BG, et al. Invasive Haemophilus influenzae disease in Alaskans aged 10 years and older before and after infant vaccination programs. JAMA.\u20082000;283:3089\u20133094","DOI":"10.1001\/jama.283.23.3089"},{"key":"2021120822383451000_R35","unstructured":"Alaska Department of Labor and Workforce Development. Alaska Unemployment Rates, 2005. Juneau, AK: Alaska Department of Labor and Workforce Development; 2005"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/2\/e421\/1074131\/zpe0080600e421.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/2\/e421\/1074131\/zpe0080600e421.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T11:17:46Z","timestamp":1683544666000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/118\/2\/e421\/68954\/The-Alaska-Haemophilus-influenzae-Type-b"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,1]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2006,8,1]]},"published-print":{"date-parts":[[2006,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2006-0287","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,1]]}}}